A Replication-Competent, Conditionally Auto-Inhibiting Vector for Delivery of HIV Cure Genetics
Project scope
Categories
Product or service launchSkills
genetic engineering gene therapy cell culture molecular biology laboratory techniquesThe students are tasked with implementing a Research Strategy designed by a group of students at Concordia University to develop the VectorGen vector. They will perform the necessary benchwork to develop the vector's unique genetic mechanism, giving them an opportunity to practice techniques of Molecular Genetics that will ultimately be used to validate this groundbreaking technology for delivery of HIV cure genetics.
About the company
VectorGen was originally formed as a funding entity for HIV cure research. Our founder has an impressive array of diverse projects that range from civic ventures to role-playing game-based learning programs.
VectorGen has been working with Riipen for well over five years, developing projects with student groups from the USA, Canada, and Australia.
Recently, VectorGen has partnered with The Visionaries, an independent venture studio for early-stage startups that provides talent, innovation, technology, and funding services with a global perspective to accelerate startup growth, delivering tailored plans and training for success in the competitive startup landscape.